Peijia Medical launches $302m Hong Kong IPO

Jonathan Breen

May 05, 2020 06:30 am

Buildings_China_PA_575X375_29Apr20 — NANNING, CHINA - APRIL 28, 2020 - The sun shines on the building complex, Nanning, Guangxi, China, April 28, 2020. Nanning real estate market. (Photo by Peng Huan / Costfoto/Sipa USA) | Costfoto/SIPA USA/PA Images

Mainland-based Peijia Medical is set to be the third healthcare company to list in Hong Kong since the coronavirus outbreak in late January, opening books on Tuesday for a HK$2.34bn ($302m) IPO.

Unlock this article.

The content you are trying to view is exclusive to our subscribers.

To unlock this article:

Request demo or Login

✔ 4,000 annual insights
✔ 700+ notes and long-form analyses
✔ 4 capital markets databases
✔ Daily newsletters across markets and asset classes
✔ 2 weekly podcasts

Topics

Equity IPOs Health and Biotech UBS Equity China Merchants Bank Co China Hong Kong SAR Asia Coronavirus Greater China Morgan Stanley Northeast Asia Guotai Junan Securities Co Asia Pacific Emerging Markets SRI

JB

Jonathan Breen

Equities editor GlobalCapital Asia